ARTICLE | Clinical News
Elan, Biogen report Antegren data
January 22, 2001 8:00 AM UTC
In a 213-patient double-blind Phase II study in the U.S., Canada and U.K., ELN and partner BGEN said that monthly injections of Antegren, a humanized monoclonal antibody against integrin a4, gave a si...